Company Overview
By using the body’s immune system, Anixa Biosciences is taking multiple approaches to fighting cancer—developing both diagnostics and therapeutics to detect cancer early, when it is most curable, and to treat those afflicted once diagnosed.
Recent News
Anixa Biosciences Receives Notice of Allowance from Canadian Intellectual Property Office for Patent Covering Breast Cancer Vaccine Technology
Anixa Biosciences Awarded New U.S. Patent Extending Breast Cancer Vaccine IP Protection into 2040s
Anixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technology
Stock Overview
Symbol
ANIX
Exchange
Nasdaq
Market Cap
103.08m
Last Price
$3.20
52-Week Range
$2.07 - $4.20
07/30/2025 02:20 PM EDT
Investor Relations
Mike Catelani
President, COO & CFO
T: 408-708-9808